Anthony Davies considers the possibility of a new CMC norm in this BPI article

In this Feb 2020 bioprocessintl.com article (click here), Dan Stanton talks to Dark Horse CEO Anthony Davies about what pattern Catalent’s $315M acquisition of Masthercell might be foreshadowing.








.

We use cookies to help give you the best experience on our website. By continuing you agree to our use of cookies.